Alkoxylates according to the following formula (I)

##STR00001##

are described, wherein X is selected from ethoxy and mixtures of ethoxy and propoxy groups, T is selected from the group consisting of H, C.sub.1-C.sub.4 alkyl, SO.sub.3.sup.−, CH.sub.2—COO.sup.−, sulfosuccinate and PO.sub.3.sup.2−, R1, R2 and R4 are H, CO—NR8R3 or COO—[X.sub.1].sub.v—R3, whereby two of the substituents R1, R2 and R4 are H and the third of these substituents is CO—NR8R3 or COO—[X.sub.1].sub.v—R3, R8 is H or a linear or branched alkyl group with 1 to 4 C-atoms, R3 is a linear or branched saturated alkyl group with 6 to 30 carbon atoms, a linear or branched mono- or polyunsaturated alkenyl group with 6 to 30 carbon atoms, an aryl group with 6 to 10 carbon atoms, a group (CH.sub.2CH.sub.2O).sub.maryl, wherein the aryl group comprises 6 to 10 carbon atoms and m, on a molar average, is a number from 1 to 100, or an aryl-substituted linear or branched C.sub.1-C.sub.3 alkyl group wherein the aryl group comprises 6 to 10 carbon atoms, but in the case, that R1 and R4 are H and R2 is COOR3, R3 can only be an alkyl group, an alkenyl group or a group (CH.sub.2CH.sub.2O).sub.maryl as defined above, X.sub.1 is selected from ethoxy and mixtures of ethoxy and propoxy groups, u on a molar average, is a number of from 3 to 100, and v on a molar average, is a number of from 0 to 20.

The compounds of formula (I) may advantageously be used as anti-redeposition agents in laundry applications.

Disclosed is a resist composition including a compound represented by formula (I), a resin having an acid-labile group and an acid generator, the resin having an acid-labile group including at least one selected from the group consisting of a structural unit represented by formula (a1-1) and a structural unit represented by formula (a1-2):

##STR00001##

Disclosed is a resist composition including a compound represented by formula (I), a resin having an acid-labile group and an acid generator, the resin having an acid-labile group including at least one selected from the group consisting of a structural unit represented by formula (a1-1) and a structural unit represented by formula (a1-2):

##STR00001##

A plasticizer, which is biodegradable, has a molecule including a central structure, at least two connecting structures and at least one side-chain structure. The central structure includes at least one of a benzene derivative and at least one amino acid. The connecting structures are respectively connected to the central structure, wherein the connecting structures include a first connecting structure and a second connecting structure. The first connecting structure is an amine group, and the second connecting structure is a carboxyl group. The side-chain structure is a chain of multiple carbon atoms, and the side-chain structure is connected to at least one of the first connecting structure and the second connecting structure. An amide bond is formed as the side-chain structure connected to the amine group, and an ester bond is formed as the side-chain structure connected to the carboxyl group.

Synthesis and characterization of novel DACT forms suitable for pharmaceutical compositions in drug delivery systems to treat cancer in humans or a warm-blooded mammals. The novel forms include but not limited to cocrystals, salts, solvates of salts, and mixtures thereof.

The present disclosure describes surface formulations that form a layer on surfaces and comprise a phenol selected from: (I), (II), (III), (IV) or (V), with detailed descriptions of variables herein.

##STR00001##

The invention provides compounds for use in inhibiting a microbial alternative oxidase (AOX) and/or cytochrome bc.sub.1 complex. The invention extends to the use of such inhibitors in agrochemicals and in pharmaceuticals, for treating microbial infections, including fungal infections.

The invention provides compounds for use in inhibiting a microbial alternative oxidase (AOX) and/or cytochrome bc.sub.1 complex. The invention extends to the use of such inhibitors in agrochemicals and in pharmaceuticals, for treating microbial infections, including fungal infections.

A fragrance precursor represented by formula (1):

##STR00001##

wherein R.sup.1 represents a hydrogen atom, an alkyl group having a carbon number of 1 to 12, a hydroxy group, a methoxy group or an ethoxy group R.sup.2 represents a single bond, an alkylene group having a carbon number of 1 to 2, which may have a substituent, or a vinylene group which may have a substituent; and R.sup.3 represents a residue resulting from removal of one hydrogen atom of a hydroxy group from a fragrance alcohol having a carbon number of 5 to 20 or a phenol which may have a substituent.

The present technology relates to synthesis of resveratrol compositions, in particular to methods of synthesizing resveratrol salicylates such as those formed through the activation of resveratrol and salicylic acid, and cosmetic and pharmaceutical compositions comprising the same.